THE UK Medicines and
Healthcare Products Regulatory
Agency has published its Business
plan for 2010/11 which outlines its
objectives as safeguarding public
health, supporting research,
influencing the future of regulatory
frameworks through international
relationships and to promote and
improve public health outcomes.
The Agency also outlays the key
challenges it foresees facing over
the next year as: launching the 3rd
communications strategy, the
implementation of a risk-based
surveillance strategy for
pharmaceutical manufacturers and
continuing to combat the threat of
counterfeit medicines and devises.
The Agency also sees the delivery
of a pilot medical devices driving
license, the review of the UK
medicines supply chain, publishing
safety updates to product information
on medicines and launching the
updated paediatric strategy as key
challenges in 2010/11.The above article was sent to subscribers in Pharmacy Daily's issue from 02 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Aug 10
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.